Distributed Bio Overview

  • Founded
  • 2010

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 32

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $104M

Distributed Bio General Information

Description

Developer of antibody discovery tools intended to be used for life sciences research and drug discovery. The company's tools offer readily formattable antibody fragments to support antibody and cell and gene therapy candidates to biopharmaceutical clients along with analysis and engineering of antibodies, TCRs and peptides and advanced antibody libraries among others, enabling healthcare professionals to recover high affinity, drug-worthy antibodies against any target.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 201 Gateway Boulevard
  • Floor 1
  • South San Francisco, CA 94080
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Distributed Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 31-Dec-2020 $104M 00000 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Distributed Bio’s complete valuation and funding history, request access »

Distributed Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antibody discovery tools intended to be used for life sciences research and drug discovery. The company's t
Biotechnology
South San Francisco, CA
32 As of 2021
0000 0000-00-00
000000&0

000000

voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occ
0000000000000
Vancouver, Canada
000 As of 0000
00000
0.000 0000-00-00
00000000 00000

000000

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
0000 000000000
Quincy, MA
00 As of 0000
000
0000 0000-00-00
000000&0 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Distributed Bio Competitors (64)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AbCellera Formerly VC-backed Vancouver, Canada 000 00000 00000000 00000
0000000 Formerly VC-backed Quincy, MA 00 000 000000&0 000
00000000 Formerly VC-backed San Carlos, CA 00 00000 000000000 00000
00000 0000 0000000 Venture Capital-Backed Wadenswil, Switzerland 00 00000 00000000000 00000
000000 00000000000 Venture Capital-Backed San Diego, CA 00 0000 0000000000 0000
You’re viewing 5 of 64 competitors. Get the full list »

Distributed Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Distributed Bio Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BroadOak Capital Partners Growth/Expansion Minority 000 0000 000000 0
Research Corporation Technologies Venture Capital Minority 000 0000 000000 0
To view Distributed Bio’s complete investors history, request access »